BioRestorative Therapies, Inc. (BRTX) vs Cadrenal Therapeutics, Inc. Common Stock (CVKD)
A side-by-side comparison of BioRestorative Therapies, Inc. and Cadrenal Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRTX
BioRestorative Therapies, Inc.
$2.30HealthcareDelayed quote: Oct 6, 2026, 10:06 AM EDT
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$0.95HealthcareDelayed quote: Oct 6, 2026, 10:07 AM EDT
Total return — BRTX vs CVKD
growth of $100 · dividends reinvested · last 4yBRTX -96.3% (-56.1%/yr)CVKD -98.5% (-64.8%/yr)BRTX compounded faster over this window
BRTX CVKD
BRTX vs CVKD: by the numbers
- •CVKD is the larger company ($3M vs $3M market cap).
- •Both run net losses; CVKD's is the smaller (0.00% vs -3089.55% net margin).
Metrics side by side
Valuation
| Metric | BRTX | CVKD |
|---|---|---|
| P/S ratio | 8.88 | N/A |
| P/B ratio | 1.05 | 0.83 |
Profitability
| Metric | BRTX | CVKD |
|---|---|---|
| Gross margin | 92.09% | 0.00% |
| Operating margin | -4350.05% | 0.00% |
| Net margin | -3089.55% | 0.00% |
| ROE | -365.43% | -282.13% |
| ROIC | -464.86% | -284.81% |
Growth (annualized)
| Metric | BRTX | CVKD |
|---|---|---|
| Revenue CAGR (5Y) | 38.99% | N/A |
| Total return CAGR (5Y) | -61.44% | N/A |
Go deeper
Dig into the metrics
BioRestorative Therapies ROECadrenal Therapeutics, Inc. Common Stock ROEBioRestorative Therapies operating marginCadrenal Therapeutics, Inc. Common Stock operating marginBioRestorative Therapies revenue growthCadrenal Therapeutics, Inc. Common Stock revenue growthBioRestorative Therapies free cash flowCadrenal Therapeutics, Inc. Common Stock free cash flow
BioRestorative Therapies & Cadrenal Therapeutics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.